NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 159 filers reported holding NOVAVAX INC in Q2 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $555,000 | -89.8% | 78,540 | -83.9% | 0.01% | -88.9% |
| Q2 2015 | $5,425,000 | -53.3% | 487,020 | -65.3% | 0.04% | -54.1% |
| Q1 2015 | $11,619,000 | +80.7% | 1,405,034 | +29.6% | 0.10% | +75.0% |
| Q4 2014 | $6,429,000 | +55.2% | 1,084,194 | +9.2% | 0.06% | +47.4% |
| Q3 2014 | $4,142,000 | -5.1% | 993,244 | +5.1% | 0.04% | -5.0% |
| Q2 2014 | $4,366,000 | +108.4% | 944,868 | +104.3% | 0.04% | +37.9% |
| Q1 2014 | $2,095,000 | +1.9% | 462,537 | +15.2% | 0.03% | -6.5% |
| Q4 2013 | $2,056,000 | +182.4% | 401,492 | +73.7% | 0.03% | +138.5% |
| Q3 2013 | $728,000 | +37.1% | 231,172 | -10.8% | 0.01% | +30.0% |
| Q2 2013 | $531,000 | – | 259,107 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |